期刊
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
卷 94, 期 2, 页码 280-284出版社
FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.13052
关键词
Cryptochrome-1; prognostic marker; chronic lymphocytic leukemia; ZAP70; LPL; IgV(H)
类别
资金
- Instituto de Salud Carlos III [P1020889, P/051001]
- Fondo de Investigaciones Sanitarias [CP03/00106]
Chronic lymphocytic leukemia is an adult-onset leukemia with a heterogeneous clinical behavior. When chronic lymphocytic leukemia cases were divided on the basis of IgV(H) mutational status, widely differing clinical courses were revealed. Since IgV(H) sequencing is difficult to perform in a routine diagnostic laboratory, finding a surrogate for IgV(H) mutational status seems an important priority. In the present study, we proposed the use of Cryptochrome-1 as a new prognostic marker in early-stage chronic lymphocytic leukemia. Seventy patients (Binet stage A, without treatment) were included in the study. We correlated Cryptochrome-1 mRNA with well established prognostic markers such as IgV(H) mutations, ZAP70, LPL or CD38 expression and chromosomal abnormalities. High Cryptochrome-1 expression correlated with IgV(H) unmutated samples. In addition, Cryptochrome-1 was a valuable predictor of disease progression in early-stage chronic lymphocytic leukemia, therefore it can be introduced in clinical practice with the advantage of a simplified method of quantification.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据